Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00124995 · ClinicalTrials.gov registry record · Phase 4
Trial of Terbutaline for the Treatment of Status Asthmaticus in Children
A Phase 4 study, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00124995 is a Phase 4 study that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT00124995, a Phase 4 study, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
Although widely used for the treatment of pediatric status asthmaticus, intravenous terbutaline has potentially significant side effects; may not improve outcomes; and may increase Intensive Care Unit (ICU) length of stay. This study is designed to test the efficacy of intravenous terbutaline for the treatment of status asthmaticus by adding intravenous terbutaline or placebo to standard asthma treatment. The dose of terbutaline or placebo will be titrated according to severity of illness as quantified by a validated clinical asthma score. Differences in outcomes between the study groups, such as length of stay, hospital costs, and lung function will be compared.
Interventions
- DRUG terbutaline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2003-10 |
| Est. Completion | 2006-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00124995
The ClinicalTrials.gov registry entry for NCT00124995 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which terbutaline is the first listed.
NCT00124995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00124995 about?
NCT00124995 is a clinical study titled "Trial of Terbutaline for the Treatment of Status Asthmaticus in Children". Although widely used for the treatment of pediatric status asthmaticus, intravenous terbutaline has potentially significant side effects; may not improve outcomes; and may increase Intensive Care Unit (ICU) length of stay. This study is designed to test the efficacy of intravenous terbutaline for th...
What is the current status of trial NCT00124995?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2003-10. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00124995?
The interventions under investigation include: terbutaline (DRUG).
Who is sponsoring clinical trial NCT00124995?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.